Ursodeoxycholic acid treatment in children with Byler disease

Pediatrics International

Volumn 41, Issue 6, 1999, Pages 662-665

  Dinler, Gönül ^a   Koçak, Nurten ^a   Özen, Hasan ^a   Yüce, Aysel ^a   Gürakan, Figen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Byler disease; Children; Progressive familial intrahepatic cholestasis; Ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; MALE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; INFANT; LIVER FUNCTION TESTS; MALE; STATISTICS, NONPARAMETRIC; URSODEOXYCHOLIC ACID;

EID: 0033405712     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.1999.01143.x     Document Type: Article

References (23)

1. 1 Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 1994; 18: 134-41.
2. 2 Gürgey A, Özsoylu Ş, Koçak N. Fatal intrahepatic cholestasis. Turk. J. Pediatr. 1976; 18: 53-7.
3. 3 Riely CA. Familial intrahepatic cholestatic syndromes. Semin. Liver Dis. 1987; 7: 119-33.
4. 4 Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred. Am. J. Dis. Child. 1969; 117: 112-24.
5. 5 Jankowska I, Kalicinski P, Pawlowska J et al. Evaluation of different methods of treatment in children with progressive familial intrahepatic cholestasis (PFIC). Falk Symposium No 107: Diseases of the Liver and Bile Ducts-New Aspects and Clinical Implications. Prague, September 12-13 Sep, 1998.
6. 6 Bull. LN, van Eijk MJT, Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 1998; 18: 219-24.
7. 7 Jacquemin E, Dumond M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur. J. Pediatr. 1994; 153: 424-8.
8. 8 Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988; 95: 130-6.
9. 9 Fausa O. Quantitative determination of serum bile acids using a purified 3a-hydroxysteroid dehydrogenase. Scand. J. Gastroenterol. 1975; 10: 747-52.
10. 10 Arrase M, Ananthanarayanan M, Suchy FJ. Hepatobiliary transport: Molecular mechanism of development and cholestasis. Pediatr. Res. 1998; 44: 141-7.
11. 11 Özsoylu Ş, Koçak N. Benign recurrent intrahepatic cholestasis. Clin. Pediatr. 1971; 10: 123-5.
12. 12 Henegouwen GP. Benign recurrent intrahepatic cholestasis and Byler's disease: One gene, two diseases? J. Hepatol. 1996; 25: 395-7.
13. 13 Khandelwal M, Malet PF. Pruritus associated with cholestasis. A review of pathogenesis and management. Dig. Dis. Sci. 1994; 39: 1-8.
14. 14 Merli M, Bertasi S, Servi R et al. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: A randomised, placebo-controlled, crossover trial. J. Pediatr. Gastroenterol. Nutr. 1994; 19: 198-203.
15. 15 Colombo C, Setchell KDR, Podda M et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J. Pediatr. 1990; 117: 482-9.
16. 16 Colombo C, Crosignani A, Assaisso M et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose response study. Hepatology 1992; 16: 924-30.
17. 17 Balistreri WF, Heubi JE, Whitington P, Perrault J, Bancroft J, Setchell KDR. Ursodeoxycholic acid therapy in pediatric hepatobiliary disease. Hepatology 1989; 10: A136.
18. 18 Dinler G, Koçak N, Yüce A, Gürakan F, Özen H. Ursodeoxycholic acid therapy in children with cholestaic liver disease. Turk. J. Pediatr. 1999; 41: 91-8.
19. 19 Kardorff R, Melter M, Rodeck B, Brodehl J. Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood-clinical and biochemical effects. Klin. Paediatr. 1996; 208: 118-22 (in German).
20. 20 Naveh Y, Bassan L, Rosenthal E et al. Progressive familial intrahepatic cholestasis among the Arab population in Israel. J. Pediatr. Gastroenterol. Nutr. 1997; 24: 548-54.
21. 21 Jacquemin E, Hermans D, Myara A et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997; 25: 519-23.
22. 22 Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R et al. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J. Pediatr. Surg. 1998; 33: 220-4.
23. 23 Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal serum gamma-glutamyl transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J. Pediatr. 1987; 11: 251-2.